AEON Biopharma (AEON) EPS (Basic) (2021 - 2026)
AEON Biopharma (AEON) posted EPS (Basic) of -$3.74 for Q4 2025, down 859.68% sequentially from -$0.39 in Q3 2025, and down 178.45% YoY from $4.77 in Q4 2024.
AEON Biopharma (AEON) EPS (Basic) (2021 - 2026) Analysis & Trends
AEON Biopharma has reported EPS (Basic) for 5 years, with the latest figure at -$3.74 in Q4 2025.
- Quarterly EPS (Basic) fell 178.45% year-over-year to -$3.74 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.95 (down 105.03% YoY) and the FY2025 annual result came in at -$3.95, down 105.09% from the prior year.
- EPS (Basic) eased to -$3.74 in Q4 2025 per AEON's latest filing, from -$0.39 in the prior quarter.
- Over five years, EPS (Basic) peaked at $304.17 in Q2 2024 and troughed at -$576.79 in Q3 2023.
- A 5-year average of -$26.18 and a median of $0.05 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) sank 67414.4% in 2023, then surged 3387.71% in 2024.
- Over 5 years, EPS (Basic) stood at $13.48 in 2021, then tumbled by 99.64% to $0.05 in 2022, then slumped by 1196779.47% to -$576.79 in 2023, then jumped by 100.83% to $4.77 in 2024, then tumbled by 178.45% to -$3.74 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$3.74, -$0.39, and -$0.6 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12 |
| Dec 31, 2025 | -3.74 |
| Sep 30, 2025 | -0.39 |
| Jun 30, 2025 | -0.60 |
| Mar 31, 2025 | 2.28 |
| Dec 31, 2024 | 4.77 |
| Sep 30, 2024 | -11.24 |
| Jun 30, 2024 | 304.17 |
| Mar 31, 2024 | -227.99 |
| Sep 30, 2023 | -576.79 |
| Jun 30, 2023 | -9.25 |
| Mar 31, 2023 | -1.40 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.86 |
| Jun 30, 2022 | 3.90 |
| Mar 31, 2022 | 5.79 |
| Dec 31, 2021 | 13.48 |
| Sep 30, 2021 | 11.81 |
| Jun 30, 2021 | -33.60 |
| Mar 31, 2021 | 20.44 |